Helen Stephens Group, LLC Ampio Pharmaceuticals, Inc. Transaction History

Helen Stephens Group, LLC

  • $327 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022
BUY
$0.56 - $1.71 $65,644 - $200,449
117,222 New
117,222 $67,000

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0
View Full List

About Ampio Pharmaceuticals, Inc.

AMPE Quotes by TradingView
  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Helen Stephens Group, LLC Portfolio

Follow Helen Stephens Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Helen Stephens Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Helen Stephens Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email